Patents by Inventor Fei Dou

Fei Dou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220048887
    Abstract: An impurity A, an impurity B and an impurity G and preparation methods therefor, and an application as a reference standard for quality control of a compound as represented by formula VI are described.
    Type: Application
    Filed: December 16, 2019
    Publication date: February 17, 2022
    Inventors: Fei DOU, Peng JING
  • Patent number: 10501452
    Abstract: The present invention relates to a lactam compound derivative, a medicine composition comprising the lactam compound derivative, and uses of the composition and the lactam compound derivative in preparation of a medicine for preventing or treating schizophrenia, the lactam compound derivative having a structure as shown in Formula I.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: December 10, 2019
    Assignee: NHWA PHARMA. CORPORATION
    Inventors: Yin Chen, Fei Dou, Yinli Qiu, Minquan Yu, Guisen Zhang
  • Patent number: 10336757
    Abstract: Treatment of neurodegenerative diseases is achieved using small molecule purine scaffold compounds that inhibit Hsp90 and that possess the ability to cross the blood-brain barrier or are other wise delivered to the brain.
    Type: Grant
    Filed: July 2, 2007
    Date of Patent: July 2, 2019
    Assignees: Sloan-Kettering Institute for Cancer Research, The Rockefeller University
    Inventors: Gabriela Chiosis, Paul Greengard, Fei Dou, Wenjie Luo, Huazhong He, Danuta Zatorska
  • Publication number: 20180327397
    Abstract: The present invention relates to a lactam compound derivative, a medicine composition comprising the lactam compound derivative, and uses of the composition and the lactam compound derivative in preparation of a medicine for preventing or treating schizophrenia, the lactam compound derivative having a structure as shown in Formula I.
    Type: Application
    Filed: November 21, 2016
    Publication date: November 15, 2018
    Inventors: Yin CHEN, Fei DOU, Yinli QUI, Minquan YU, Guisen ZHANG
  • Publication number: 20090298857
    Abstract: Treatment of neurodegenerative diseases is achieved using small molecule purine scaffold compounds that inhibit Hsp90 and that possess the ability to cross the blood-brain barrier or are other wise delivered to the brain.
    Type: Application
    Filed: July 2, 2007
    Publication date: December 3, 2009
    Applicants: SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH, THE ROCKEFELLER UNIVERSITY
    Inventors: Gabriela Chiosis, Paul Greengard, Fei Dou, Wenjie Luo